CharlesLLudivicoMD

Rheumatology • Fountain Hill, PA

Rheumatoid Arthritis & Related

Physician

Join to view full profile

Dr. Ludivico is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ludivico's full profile

Already have an account?

Office
701 Ostrum St
Ste 302
Fountain Hill, PA 18015
Phone+1 610-868-1336

Fax+1 610-332-2436

Education & Training

University of Pennsylvania Health SystemFellowship, Rheumatology, 1975 - 1977
Temple University HospitalResidency, Internal Medicine, 1970 - 1973
Lewis Katz School of Medicine at Temple UniversityClass of 1970

Certifications & Licensure

NJ State Medical License Current
PA State Medical License 1971 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22
Terminated
Phase 2

Publications & Presentations

PubMed

422 citations
Baricitinib in Patients with Refractory Rheumatoid Arthritis
Mark C. Genovese, Joel M. Kremer, Omid Zamani, Charles Ludivico, Marek Krogulec
The New England Journal of Medicine. 2016-03-30
89 citations
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, Stephen B. Hall, Piotr Leszczyński
Annals of the Rheumatic Diseases. 2014-06-01
193 citations
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional ...
Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, Stephen B. Hall, Piotr Leszczyński
Annals of the Rheumatic Diseases. 2014-01-01

Professional Memberships

American College of Rheumatology - ACR
Fellow

Other Languages

Sign Language (American)